Dapsone
6,989 views
Antibiotics / Antiparasitics
- Penicillin Overview
- Penicillinase-Sensitive vs. Penicillinase-Resistant Penicillins
- Anti-Pseudomonal Penicillins
- Cephalosporins Overview
- 1st Generation Cephalosporins
- 2nd Generation Cephalosporins
- 3rd Generation Cephalosporins
- 4th Generation Cephalosporins
- 5th Generation Cephalosporins
- Carbapenems
- Monobactams (Aztreonam)
- Vancomycin
- Aminoglycosides
- Tetracyclines
- Tigecycline
- Chloramphenicol
- Clindamycin
- Linezolid
- Macrolides
- Polymyxins
- Sulfonamides
- Dapsone
- Trimethoprim
- Fluoroquinolones
- Daptomycin
- Metronidazole
- Rifamycins (Rifampin, Rifabutin)
- Isoniazid
- Pyrazinamide
- Ethambutol
- Chloroquine
Summary
Dapsone is an antibiotic that works by inhibiting bacterial folate synthesis. It is clinically used to treat leprosy and pneumocystis pneumonia. Side effects include hemolysis in patients with G6PD deficiency, rare bone marrow failure or agranulocytosis, as well as induction of methemoglobinemia by way of oxidizing the iron in heme to its Fe3+ form.
Key Points
- Dapsone
- Mechanism
- Inhibits bacterial folate synthesis
- Via competitive antagonism of para-aminobenzoic acid (PABA)
- Similar to sulfonamides, but structurally distinct agent
- Inhibits bacterial folate synthesis
- Clinical Use
- M. leprae (leprosy)
- Pneumocystis jiroveci prophylaxis and treatment
- Adverse Effects
- Hemolysis in G6PD
- Dapsone is an oxidizing agent and can increase oxidative stress on RBCs
- Methemoglobinemia
- Dapsone is an oxidizing agent
- Oxidizes Fe2+ (ferrous iron) in heme to Fe3+ (ferric iron)
- Agranulocytosis
- Hemolysis in G6PD
- Mechanism